| Value | ₹19.12 Cr |
|---|
BSE filing, NSE: DECNGOLD. Summary written from the filing by ALFA Finder's alert engine.
Deccan Gold Mines Ltd: key numbers
- Share price
- ₹171.90
- Market cap
- ₹3,386 Cr
- Revenue (annual)
- ₹14.20 Cr
- Net profit (annual)
- ₹-52.60 Cr
- P/E (TTM)
- -98.1×Sector 16.9×
- Promoter holding
- 20.30%-0.23% QoQ
- FII holding
- 2.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Deccan Gold Mines Ltd
All →Deccan Gold Mines Business Update
Deccan Gold reports maiden drilling at Spain's Logrosan project intersected economic tungsten-tin mineralisation in all eight holes. Preliminary model suggests over 2,000 tonnes of WO3 potential.
Deccan Gold Mines Other Announcement
Deccan Gold Mines Ltd has filed its quarterly shareholding pattern as mandated under Regulation 31 of SEBI LODR for the period ended September 30, 2026.
Deccan Gold Mines Capital Structure Change
Deccan Gold Mines Limited has allotted 34,000 equity shares under its ESOP scheme. The allotment increases the company's paid-up share capital.
Deccan Gold Mines Employee Stock Options
Deccan Gold Mines Limited allotted 34,000 equity shares following the exercise of stock options. This exercise realized Rs. 0.07 Crore under the company's 2024 stock incentive plan.
- Value
- ₹0.07 Cr
Deccan Gold Mines Legal & Regulatory
Deccan Gold provided an update on Supreme Court proceedings regarding the Ganajur Mining Lease, noting its subsidiary will have an opportunity to present its case.
Deccan Gold Mines Annual General Meeting
Deccan Gold Mines held its 42nd AGM, transacting business including financial statement adoption, director re-appointments, and material related party transaction approvals.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.